|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
JP2898040B2
(ja)
|
1990-01-26 |
1999-05-31 |
忠三 岸本 |
ｇｐ１３０蛋白質に対する抗体
|
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
|
US6129914A
(en)
|
1992-03-27 |
2000-10-10 |
Protein Design Labs, Inc. |
Bispecific antibody effective to treat B-cell lymphoma and cell line
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
CA2157577C
(en)
|
1993-03-19 |
2009-11-17 |
Se-Jin Lee |
Growth differentiation factor-8
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
US5856098A
(en)
|
1994-09-14 |
1999-01-05 |
Progenitor, Inc. |
Detection of a leptin receptor variant
|
|
US5643748A
(en)
|
1994-09-14 |
1997-07-01 |
Progenitor, Inc. |
HU-B1.219, a novel human hematopoietin receptor
|
|
US6451523B1
(en)
|
1994-09-14 |
2002-09-17 |
Interneuron Pharmaceuticals, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
|
US5912123A
(en)
|
1994-09-14 |
1999-06-15 |
Progenitor, Inc. |
Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
|
|
FR2733250B1
(fr)
|
1995-04-21 |
1997-07-04 |
Diaclone |
Anticorps monoclonaux anti-gp130, et leurs utilisations
|
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
|
US6977240B1
(en)
|
1995-11-27 |
2005-12-20 |
Millenium Pharmaceuticals, Inc. |
Methods of using the OB receptor antibodies to treat bodyweight disorders
|
|
US20050019325A1
(en)
|
1996-01-08 |
2005-01-27 |
Carter Paul J. |
WSX receptor agonist antibodies
|
|
AU721129B2
(en)
|
1996-01-08 |
2000-06-22 |
Genentech Inc. |
WSX receptor and ligands
|
|
US7063958B1
(en)
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
|
AU2476301A
(en)
|
1996-01-16 |
2001-05-24 |
Rockefeller University, The |
DB the receptor for leptin nucleic acids encoding the receptor, and uses thereof
|
|
AU1833197A
(en)
|
1996-01-18 |
1997-08-11 |
Progenitor, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
|
AU731685C
(en)
|
1996-01-23 |
2002-08-22 |
Indevus Pharmaceuticals, Inc. |
Methods for using the obese gene and its gene product to stimulate hematopoietic development
|
|
US7067472B1
(en)
|
1996-06-04 |
2006-06-27 |
The Scripps Research Institute |
Diagnostic and therapeutic methods related to regulating energy mobilization with OB protein and OB antibodies
|
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
|
US5965521A
(en)
|
1997-02-25 |
1999-10-12 |
Eli Lilly Company |
Pulsatile delivery of leptin receptor ligands
|
|
IL120733A0
(en)
|
1997-04-29 |
1997-08-14 |
Yeda Res & Dev |
Leptin as an inhibitor of cell proliferation
|
|
US6696411B1
(en)
|
1998-04-22 |
2004-02-24 |
Cornell Research Foundation, Inc. |
Canine erythropoietin gene and recombinant protein
|
|
GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
|
US6096002A
(en)
|
1998-11-18 |
2000-08-01 |
Bioject, Inc. |
NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
|
|
WO2000032634A1
(en)
|
1998-12-01 |
2000-06-08 |
Protein Design Labs, Inc. |
Humanized antibodies to gamma-interferon
|
|
AU767068B2
(en)
|
1999-06-11 |
2003-10-30 |
Baylor College Of Medicine |
Methods and compositions for control of bone formation via modulation of leptin activity
|
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20040253242A1
(en)
|
2000-12-05 |
2004-12-16 |
Bowdish Katherine S. |
Rationally designed antibodies
|
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
ATE475094T1
(de)
|
2001-10-22 |
2010-08-15 |
Amgen Inc |
Verwendung von leptin zur behandlung von lipoatrophie im menschen und verfahren zur bestimmmung einer prädisposition gegenüber der behandlung
|
|
KR100459493B1
(ko)
*
|
2002-01-31 |
2004-12-03 |
김기수 |
골다공증의 발생 위험을 예측하는 방법 및 이를 이용한골다공증의 유전적 위험 인자에 대한 진단 키트
|
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
FR2852397B1
(fr)
|
2003-03-10 |
2005-04-29 |
|
Utilisation des genes leprotl 1 et ob-rgrp pour le criblage de composes actifs sur la prise ou la perte de poids ou le diabete d'un sujet humain ou animal.
|
|
DE10353593A1
(de)
|
2003-11-17 |
2005-06-23 |
Klinikum der Universität München Großhadern-Innenstadt |
Leptinantagonist und Verfahren zur quantitativen Messung von Leptin
|
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
|
US20070178095A1
(en)
|
2004-03-23 |
2007-08-02 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
US7863240B2
(en)
|
2004-10-08 |
2011-01-04 |
Enzo Therapeutics, Inc. |
Methods and uses of leptin in hepatocellular carcinoma
|
|
US8969291B2
(en)
|
2004-10-08 |
2015-03-03 |
Enzo Therapeutics, Inc. |
Methods for decreasing leptin levels or activity for treating inflammation
|
|
EP1802193B1
(en)
|
2004-10-19 |
2014-04-30 |
Regeneron Pharmaceuticals, Inc. |
Method for generating a mouse homozygous for a genetic modification
|
|
EP1812038A1
(en)
|
2004-11-18 |
2007-08-01 |
VIB vzw |
Fibronectin iii domain as leptin receptor antagonists
|
|
US7307142B2
(en)
|
2004-11-26 |
2007-12-11 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
Leptin antagonists
|
|
TW200724548A
(en)
|
2005-04-25 |
2007-07-01 |
Pfizer |
Antibodies to myostatin
|
|
CA2606102C
(en)
|
2005-04-26 |
2014-09-30 |
Medimmune, Inc. |
Modulation of antibody effector function by hinge domain engineering
|
|
US7888486B2
(en)
|
2005-08-19 |
2011-02-15 |
Wyeth Llc |
Antagonist antibodies against GDF-8
|
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
|
KR101135220B1
(ko)
|
2005-10-06 |
2012-04-24 |
일라이 릴리 앤드 캄파니 |
항-마이오스타틴 항체
|
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
HRP20130320T1
(en)
|
2006-09-05 |
2013-05-31 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
US8652466B2
(en)
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
|
GB0715216D0
(en)
|
2007-08-03 |
2007-09-12 |
Asterion Ltd |
Leptin
|
|
WO2009045900A2
(en)
|
2007-09-28 |
2009-04-09 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating or preventing diseases associated with low bone mass
|
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
|
US9221902B2
(en)
|
2008-11-07 |
2015-12-29 |
Fabrus, Inc. |
Combinatorial antibody libraries and uses thereof
|
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
|
DK3241435T3
(da)
|
2009-07-08 |
2021-08-23 |
Kymab Ltd |
Dyremodeller og terapeutiske molekyler
|
|
SG183149A1
(en)
|
2010-02-08 |
2012-09-27 |
Regeneron Pharma |
Common light chain mouse
|
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
|
RU2603093C2
(ru)
|
2010-04-15 |
2016-11-20 |
Дженентек, Инк. |
Антитела против полиубиквитина и способы их применения
|
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
CN105859889B
(zh)
*
|
2010-11-17 |
2020-01-07 |
中外制药株式会社 |
具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
|
|
RU2013139267A
(ru)
|
2011-02-10 |
2015-03-20 |
Рош Гликарт Аг |
Улучшенная иммунотерапия
|
|
CN105861548B
(zh)
|
2011-02-25 |
2020-01-10 |
瑞泽恩制药公司 |
Adam6小鼠
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
ES2872081T3
(es)
|
2011-08-05 |
2021-11-02 |
Regeneron Pharma |
Ratones con cadena ligera universal humanizada
|
|
SMT201800092T1
(it)
|
2011-11-14 |
2018-03-08 |
Regeneron Pharma |
Composizioni e metodi per aumentare la massa muscolare e la forza muscolare antagonizzando specificamente gdf8 e/o activina a
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
US20140013456A1
(en)
|
2012-03-16 |
2014-01-09 |
Regeneron Pharmaceuticals, Inc. |
Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
|
|
SG10201609535TA
(en)
|
2012-06-05 |
2017-01-27 |
Regeneron Pharma |
Methods for making fully human bispecific antibodies using a common light chain
|
|
FI3366705T3
(fi)
|
2012-09-12 |
2023-07-28 |
Genzyme Corp |
Muuttuneen glykosylaation ja vähentyneen efektoritoiminnan omaavia fc:n sisältäviä polypeptidejä
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
TWI655207B
(zh)
|
2013-07-30 |
2019-04-01 |
再生元醫藥公司 |
抗活化素ａ之抗體及其用途
|
|
EP3108255B1
(en)
|
2014-02-18 |
2020-08-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of diseases mediated by the nrp-1/obr complex signaling pathway
|
|
US20160075772A1
(en)
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
|
WO2016168613A1
(en)
|
2015-04-15 |
2016-10-20 |
Regeneron Pharmaceuticals, Inc. |
Methods of increasing strength and functionality with gdf8 inhibitors
|
|
TWI824372B
(zh)
|
2015-10-12 |
2023-12-01 |
美商再生元醫藥公司 |
活化瘦素受體的抗原結合蛋白
|
|
MA45801B1
(fr)
|
2016-11-08 |
2021-11-30 |
Regeneron Pharma |
Protéines de liaison à l'antigène qui sont des antagonistes du récepteur de leptine
|
|
CN107760761A
(zh)
|
2017-11-10 |
2018-03-06 |
江苏省农业科学院 |
一种加强瘦素激发lepr信号转导的方法
|
|
SG11202005146VA
(en)
|
2017-12-18 |
2020-06-29 |
Regeneron Pharma |
Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
|
|
US10131622B1
(en)
|
2018-01-03 |
2018-11-20 |
Saudi Arabian Upstream Technology Company |
N-hydroxyalkylated polyamines, methods of making N-hydroxyalkylated polyamines, and fluids containing an N-hydroxyalkylated polyamine
|
|
IL276921B2
(en)
|
2018-03-01 |
2025-12-01 |
Regeneron Pharma |
Methods for altering body composition
|
|
SMT202500283T1
(it)
|
2018-04-06 |
2025-09-12 |
Regeneron Pharma |
Un anticorpo agonista del recettore della leptina da utilizzare per aumentare la massa ossea in un soggetto affetto da disfunzione metabolica o ipoleptinemia
|
|
CN113195532B
(zh)
|
2018-12-18 |
2025-04-11 |
瑞泽恩制药公司 |
使用针对瘦素受体、gdf8和活化素a的拮抗剂增加体重和瘦肌肉质量的组合物和方法
|
|
BR112023004716A2
(pt)
|
2020-09-15 |
2023-05-09 |
Regeneron Pharma |
Uso de agonistas de lepr para dor
|